Clinical and Pathologic Spectrum of DDX41-Mutated Hematolymphoid Neoplasms.

Tanu GoyalZheng Jin TuZhen WangJames R Cook

Published in: American journal of clinical pathology (2021)

This report extends the spectrum of DDX41-mutated disorders to include CCUS, T-LGL, and plasma cell disorders. The morphologic features are heterogeneous and nonspecific, highlighting the importance of DDX41 testing during routine workup of hematolymphoid neoplasms.

Keyphrases

single cell
neoadjuvant chemotherapy
cell therapy
clinical practice
wild type
stem cells
rectal cancer